(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "HIV-2 Protease (HIV-2 PR) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the HIV-2 Protease (HIV-2 PR) Inhibitors. The Publisher's Report covers the product...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Glutamate Receptor Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Glutamate Receptor Antagonists. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, January 28, 2017 ) Process Analyzers are engineering precision equipment used for incessant monitoring of parameters such as gas and liquid content during the manufacturing process. It has redefined the way by which companies carry out their production and improve the overall...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Uterine Fibroids-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Uterine Fibroids. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors. The Publisher's...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Pain Management Drugs and Devices market is expected to grow from $39.48 billion in 2015 to reach $58.2 billion by 2022 with a CAGR of 5.7%. Growing various pain disorders coupled with increasing global geriatric people is...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Home Healthcare market is expected to grow from $229.83 billion in 2015 to reach $449.56 billion by 2022 with a CAGR of 10.1%. Growing global geriatric population, raising health diseases, and cost efficiency of home healthcare...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Systemic Mastocytosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Systemic Mastocytosis. The DelveInsight'sReport covers the product profiles in various stages...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Diagnostic Imaging market is expected to grow from $30.28 billion in 2015 to reach $48.86 billion by 2022 with a CAGR of 7.1%. Increasing aging population and chronic diseases and increasing consciousness about early disease...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Severe Psoriasis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Severe Psoriasis. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Virus Filtration market is estimated at $1.96 billion in 2015 and is expected to reach $4.81 billion by 2022 growing at a CAGR of 13.7% from 2015 to 2022. Rising Government Support for Pharmaceutical & Biotechnology Industries...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Organ Preservation market is estimated at $153.93 million in 2015 and is expected to reach $274.19 million by 2022 growing at a CAGR of 8.7% from 2015 to 2022. Organ failure cases in ageing population, Organ donation campaign...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cystic Fibrosis Transmembrane Conductance Regulator...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Reperfusion Injury-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Reperfusion Injury. The DelveInsight's Report covers the product profiles in various stages of...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "CD 33 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 33 Inhibitors. The Publisher's Report covers the product profiles in various stages of development...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
